AIM
ACRS icon

Assured Investment Management’s Aclaris Therapeutics ACRS Stock Holding History

Assured Investment Management’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-55,784
Closed -$334K – 49
2019
Q1 		$334K Buy
55,784
+31,493
+130% +$209K ﹤0.01% 688
2018
Q4 		$180K Buy
+24,291
New +$250K 0.01% 898

Other funds holding ACRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Assured Investment Management's ACRS Position: Q2 2019 in Review

Assured Investment Management sold out of Aclaris Therapeutics (ACRS) in Q2 2019, closing a stake of 55,784 shares — an estimated $334K sold.

Assured Investment Management first reported a position in ACRS in Q4 2018 and held it in 2 quarters. The position peaked at $334K in Q1 2019. 84 funds tracked by Wall St. Rank hold ACRS as of Q2 2019.

  • Assured Investment Management reported no remaining Aclaris Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 55,784 Aclaris Therapeutics shares in Q2 2019, an estimated $334K.
  • Assured Investment Management first reported a position in Aclaris Therapeutics in Q4 2018 and held it in 2 quarters.
  • Assured Investment Management's Aclaris Therapeutics position peaked at $334K in Q1 2019.
  • 84 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.